Modern PsychedelicsAncient RootsPatient Impact
Cubed Biotech is a licensed Canadian psychedelic biotech redefining mental health treatment. With a 18,700 sq ft GMP-grade facility in Montreal, our platform spans cultivation & extraction of natural entheogens, chemical synthesis of novel psychedelic-inspired molecules, and clinical deployment.
perfect for
Psychedelics, Novel Molecules & Therapeutic Centers.
01.
Classic Psychedelics
Natural Entheogen Manufacturing of Psilocybin, Mescaline, DMT & MDMA
Our vertically integrated model allows us to grow, harvest, and process entheogens all under one roof, setting a new industry standard in psychedelic manufacturing. By combining biotechnology with botanical medicine, we’re developing full-spectrum and isolate-based treatments for mental health and addiction. These natural APIs form the backbone of both our internal drug development pipeline and our licensed offerings for clinical trials, academic studies, and therapeutic access programs in Canada, US, Australial and abroad.
02.
Novel Drug Development
Searching for sub-prectual non-hallucinogenic psychedelics
By decoupling the therapeutic benefits of psychedelics from the hallucinogenic experience, we aim to expand access to a broader population, including those in traditional psychiatric care settings. Our pipeline includes over 50 novel tryptamine-phenethylamine hybrids, each optimized for efficacy, safety, and scalability. Backed by strategic IP filings, academic partnerships, and Health Canada licensure, our approach combines the scientific rigor of pharma with the creativity of psychedelic science.
03.
Psychedelic Therapy
Voyage Therapeutics
Cubed Biotech will launch Voyage Therapeutics, a direct-to-patient psychedelic therapy model designed to safely deliver entheogenic treatments in medically supervised and legally regulated environments. These therapeutic dosing centers—rolling out state-by-state as regulations permit—offer full-spectrum, natural psychedelics grown and produced in-house, administered by licensed physicians and trained therapists in serene, intentionally designed clinical spaces.
Cubed
Precision Psychedelics.
Natural Psychedelic Manufacturing
We are pioneering the pharmaceutical-grade cultivation, extraction, and purification of natural psychedelics—specifically psilocybin from mushrooms, mescaline from cacti, and DMT from ayahuasca. Using advanced bioreactor systems, strain-specific mycology, and solvent-based extraction methods, we produce ultra-pure active pharmaceutical ingredients (APIs) that reflect both the precision of modern chemistry and the wisdom of historical ethnobotany.
Novel Drug Development
Our novel drug discovery program focuses on synthesizing proprietary hybrid molecules—non-hallucinogenic compounds designed to target serotonin and other neuroreceptor pathways for mood regulation, neuroplasticity, and emotional resilience. Our lead candidate, CB-002 “Ocelot,” is a breakthrough class of 5-HT2A modulators offering antidepressant and anxiolytic effects without hallucinations.
Therapeutic Clinics
Each center will be equipped to support up to 25 patients per day with one-on-one or small-group dosing sessions. With medical oversight from on-site doctors and nurses, and integration therapy provided by experienced guides, we bridge the gap between ancient healing practices and modern clinical care.